Latest News & Updates of Loncom Pharma

FDA updates nonclinical testing terminology, supporting broader use of scientifically valid NAMs in drug development while maintaining safety standards.

LONCOM connects global pharmaceutical partners through API supply, finished dosage forms, pharmaceutical R&D, and contract manufacturing solutions.

FDA’s latest 55 draft PSGs further clarify generic drug development, with continued focus on complex products and science-based BE approaches.

Jinan Mayor Yu Haitan visited Bestcomm Pharma to learn about its pharmaceutical R&D capabilities, innovation platforms, and business development.